LGND earnings
Ligand Pharmaceuticals (LGND) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
LGND earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Oct 29, 2026 | 2.67 | 2.33 | 14.59% | $78.75M |
| Q2 2026 | Aug 6, 2026 | 2.37 | 2.01 | 17.91% | $63.69M |
| Q1 2026 | May 14, 2026 | 1.63 | 1.84 | -11.41% | $51.72M |
| Q4 2025 | Feb 26, 2026 | 2.02 | 1.46 | 38.36% | $59.67M |
| Q3 2025 | Nov 6, 2025 | 3.09 | 1.97 | 56.85% | $115.46M |
| Q2 2025 | Aug 7, 2025 | 1.60 | 1.42 | 12.68% | $47.63M |
| Q1 2025 | May 8, 2025 | 1.33 | 1.21 | 9.92% | $45.33M |
| Q4 2024 | Feb 27, 2025 | -1.64 | 1.37 | -219.71% | $42.81M |
| Q3 2024 | Nov 7, 2024 | -0.39 | 1.35 | -128.89% | $51.81M |
| Q2 2024 | Aug 6, 2024 | 1.40 | 1.06 | 32.08% | $41.53M |
| Q1 2024 | May 6, 2024 | 1.20 | 0.78 | 53.85% | $30.98M |
| Q4 2023 | Feb 26, 2024 | 1.05 | 0.66 | 58.85% | $28.10M |
| Nov 7, 2023 | 1.02 | 0.61 | 67.21% | – | |
| Aug 8, 2023 | 1.42 | 0.64 | 121.87% | – | |
| May 4, 2023 | 2.28 | 0.89 | 156.18% | – | |
| Feb 22, 2023 | 1.36 | 1.19 | 14.29% | – | |
| Nov 7, 2022 | 0.41 | 0.45 | -8.89% | – | |
| Aug 8, 2022 | 0.34 | 0.43 | -20.93% | – | |
| May 4, 2022 | 0.58 | 0.66 | -12.12% | – | |
| Feb 17, 2022 | 1.80 | 0.97 | 85.57% | – |
- LGND beat EPS estimates in 75 of its last 130 reports.
Updated 2026-11-02 23:14 UTC